abrdn Australia Equity Fund, Inc is a US-based company operating in industry. abrdn Australia Equity Fund, Inc. (Fund) is a non-diversified, closed-end management investment company. The Fund's principal investment objective is long-term capital appreciation through investment primarily in equity securities of Australian companies listed on the Australian Stock Exchange Limited (ASX). Its secondary objective is current income, which is expected to be derived primarily from dividends and interest on Australian corporate and governmental securities. The Fund will invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities, consisting of common stock, preferred stock and convertible stock, of Australian companies. The company invests in various sectors, such as financials, materials, healthcare, utilities, energy, real estate, consumer discretionary, industrials, information technology, and communication services. The Fund’s investment manager is abrdn Asia Limited.
最新の財務諸表(Form-10K)によると、Boundless Bio Incの総資産は$0で、純損失は$0です。
IAFの主要な財務比率は何ですか?
Boundless Bio Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
abrdn Australia Equity Fund, Incの収益はセグメントまたは地域別にどのように分けられていますか?
Boundless Bio Inc の最大収益セグメントは SCOR Global L&H で、最新の利益発表における収益は 8,426,000,000 です。地域別に見ると、United States が Boundless Bio Inc の主要市場であり、収益は 7,008,000,000 です。